TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and ...

YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced it ...

BURLINGAME, Calif. and TOKYO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Hinge Bio, Inc., a privately-held biotechnology company engaged in the discovery and development of innovative medicines, announced it ...

Entera Bio Ltd. reported its financial results for Q1 2025, highlighting significant advancements in its development of oral peptide therapies, particularly EB613, an oral anabolic treatment for ...

NEW YORK--(BUSINESS WIRE)--Peak Bio Co., Ltd. (“Peak Bio”), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory ...

Wearable Devices expands its AI-powered LMM technology into predictive health monitoring and cognitive state analytics, enhancing real-time health insights. Wearable Devices Ltd., a technology company ...

Karo Bio AB (publ) and Alkem Laboratories Ltd have entered into a collaboration and license agreement regarding eprotirome, currently in late-stage clinical testing for dyslipidemia. Karo Bio will ...

GUANGZHOU, China, Jan. 14, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd. today announced the publication of the Phase I clinical study results for BAT4406F, an ADCC-enhanced fully humanized anti-CD20 ...

GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions Ltd (“Bio-Thera”) announced today that it has reached a licensing agreement with Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter ...